Literature DB >> 27789925

Choosing non-oral, long-acting reversible contraception.

Mary Stewart1, Deborah Bateson2.   

Abstract

Keywords:  contraceptive implant; depot contraception; intrauterine contraception device; medroxyprogesterone acetate

Year:  2016        PMID： 27789925      PMCID： PMC5079780          DOI： 10.18773/austprescr.2016.057

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  12 in total

Review 1.  The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review.

Authors:  Maureen K Baldwin; Alison B Edelman
Journal:  J Adolesc Health       Date:  2013-04       Impact factor: 5.012

2.  Effectiveness of long-acting reversible contraception.

Authors:  Brooke Winner; Jeffrey F Peipert; Qiuhong Zhao; Christina Buckel; Tessa Madden; Jenifer E Allsworth; Gina M Secura
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

3.  The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review.

Authors:  P C Schwallie; J R Assenzo
Journal:  Contraception       Date:  1974-08       Impact factor: 3.375

4.  Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.

Authors:  B Xiao; T Zeng; S Wu; H Sun; N Xiao
Journal:  Contraception       Date:  1995-06       Impact factor: 3.375

5.  Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil.

Authors:  J Díaz; A Faúndes; M Díaz; N Marchi
Journal:  Contraception       Date:  1993-02       Impact factor: 3.375

6.  Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate.

Authors:  T E Canto De Cetina; P Canto; M Ordoñez Luna
Journal:  Contraception       Date:  2001-03       Impact factor: 3.375

7.  Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.

Authors:  P G Crosignani; P Vercellini; P Mosconi; S Oldani; I Cortesi; O De Giorgi
Journal:  Obstet Gynecol       Date:  1997-08       Impact factor: 7.661

8.  Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device.

Authors:  B L Xiao; L Y Zhou; X L Zhang; M C Jia; T Luukkainen; H Allonen
Journal:  Contraception       Date:  1990-04       Impact factor: 3.375

Review 9.  The effects of Implanon on menstrual bleeding patterns.

Authors:  Diana Mansour; Tjeerd Korver; Maya Marintcheva-Petrova; Ian S Fraser
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-06       Impact factor: 1.848

10.  A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.

Authors:  S Said; K Omar; S Koetsawang; O Kiriwat; Y Srisatayapan; A Kazi; F Ajmal; H H Wynter; A Pretnar-Darovec; I B Benitez
Journal:  Contraception       Date:  1987-06       Impact factor: 3.375
View more
  1 in total

1.  The Effects of Oral Contraceptives on Exercise Performance in Women: A Systematic Review and Meta-analysis.

Authors:  Kirsty J Elliott-Sale; Kelly L McNulty; Paul Ansdell; Stuart Goodall; Kirsty M Hicks; Kevin Thomas; Paul A Swinton; Eimear Dolan
Journal:  Sports Med       Date:  2020-10       Impact factor: 11.136
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.